CLINICAL_TRIALS
trial_result
· 2022-01-25
Clinical Trial Update: High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors [Phase 2]
Summary
Phase 2 trial exploring high-dose chemotherapy with amifostine and autologous stem cell transplantation for high-risk relapsed pediatric solid and brain tumors;…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Solid Tumors, Brain Tumors | Phase 2 | Status: TERMINATED | Results posted: 2022-01-25